Central Obesity is Associated With Neuropathy in the Severely Obese

被引:65
作者
Callaghan, Brian C. [1 ]
Reynolds, Evan [1 ]
Banerjee, Mousumi [1 ]
Chant, Ericka [1 ]
Villegas-Umana, Emily [1 ]
Feldman, Eva L. [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
关键词
QUALITY-OF-LIFE; DIABETIC-NEUROPATHY; METABOLIC SYNDROME; RISK-FACTORS; DIAGNOSIS; POLYNEUROPATHY; PREVALENCE; SEVERITY; COHORT;
D O I
10.1016/j.mayocp.2020.03.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the prevalence of neuropathy stratified by glycemic status and the association between extensive anthropometric measurements and neuropathy. Patients and Methods: We performed a cross-sectional, observational study in obese individuals, before surgery, with body mass index (BMI) greater than 35 kg/m(2). Lean controls were recruited from a research website. Neuropathy was defined by the Toronto consensus definition of probable neuropathy. We compared nine anthropometric measurements between obese participants with and without neuropathy. We used multivariable logistic regression to explore associations between these measures, and other metabolic risk factors, and neuropathy. Results: We recruited 138 obese individuals and 46 lean controls. The mean age (SD) was 45.1 (11.3) years in the obese population (76.1% female, n=105) and 43.8 (12.1) years in the lean controls (82.2% female, n=37). The prevalence of neuropathy was 2.2% (n=1) in lean controls, 12.1% (n=4) in obese participants with normoglycemia, 7.1% (n=4) in obese participants with pre-diabetes, and 40.8% (n=20) in obese participants with diabetes (p<.01). Waist circumference was the only anthropometric measure that was larger in those with neuropathy (139.3 cm vs 129.1 cm, p=.01). Hip-thigh (71.1 cm vs 76.6 cm, p<.01) and mid-thigh (62.2 cm vs 66.3 cm, p=.03) circumferences were smaller in those with neuropathy. The body mass index was comparable between patients who were obese with and without neuropathy (p= .86) . Waist circumference (odds ratio [OR], 1.39; 95% CI, 1.10 to 1.75), systolic blood pressure (OR, 2.89; 95% CI, 1.49 to 5.61), and triglycerides (OR, 1.31; 95% CI, 1.00 to 1.70) were significantly associated with neuropathy. Conclusion: Normoglycemic obese patients have a high prevalence of neuropathy indicating that obesity alone may be sufficient to cause neuropathy. Waist circumference, but not general obesity, is significantly associated with neuropathy. (C) 2020 Mayo Foundation for Medical Education an Research
引用
收藏
页码:1342 / 1353
页数:12
相关论文
共 34 条
[1]   Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark [J].
Andersen, Signe T. ;
Witte, Daniel R. ;
Dalsgaard, Else-Marie ;
Andersen, Henning ;
Nawroth, Peter ;
Fleming, Thomas ;
Jensen, Troels M. ;
Finnerup, Nanna B. ;
Jensen, Troels S. ;
Lauritzen, Torsten ;
Feldman, Eva L. ;
Callaghan, Brian C. ;
Charles, Morten .
DIABETES CARE, 2018, 41 (05) :1068-1075
[2]   THE PREVALENCE OF SYMPTOMATIC, DIABETIC NEUROPATHY IN AN INSULIN-TREATED POPULATION [J].
BOULTON, AJM ;
KNIGHT, G ;
DRURY, J ;
WARD, JD .
DIABETES CARE, 1985, 8 (02) :125-128
[3]   Longitudinal patient-oriented outcomes in neuropathy Importance of early detection and falls [J].
Callaghan, Brian ;
Kerber, Kevin ;
Langa, Kenneth M. ;
Banerjee, Mousumi ;
Rodgers, Ann ;
McCammon, Ryan ;
Burke, James ;
Feldman, Eva .
NEUROLOGY, 2015, 85 (01) :71-79
[4]   Diabetes and obesity are the main metabolic drivers of peripheral neuropathy [J].
Callaghan, Brian C. ;
Gao, LeiLi ;
Li, Yufeng ;
Zhou, Xianghai ;
Reynolds, Evan ;
Banerjee, Mousumi ;
Pop-Busui, Rodica ;
Feldman, Eva L. ;
Ji, Linong .
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2018, 5 (04) :397-405
[5]   Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologists [J].
Callaghan, Brian C. ;
Xia, Rong ;
Reynolds, Evan ;
Banerjee, Mousumi ;
Burant, Charles ;
Rothberg, Amy ;
Pop-Busui, Rodica ;
Villegas-Umana, Emily ;
Feldman, Eva L. .
CLINICAL NEUROPHYSIOLOGY, 2018, 129 (03) :654-662
[6]   Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population [J].
Callaghan, Brian C. ;
Xia, Rong ;
Reynolds, Evan ;
Banerjee, Mousumi ;
Rothberg, Amy E. ;
Burant, Charles F. ;
Villegas-Umana, Emily ;
Pop-Busui, Rodica ;
Feldman, Eva L. .
JAMA NEUROLOGY, 2016, 73 (12) :1468-1476
[7]   Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status [J].
Callaghan, Brian C. ;
Xia, Rong ;
Banerjee, Mousumi ;
de Rekeneire, Nathalie ;
Harris, Tamara B. ;
Newman, Anne B. ;
Satterfield, Suzanne ;
Schwartz, Ann V. ;
Vinik, Aaron I. ;
Feldman, Eva L. ;
Strotmeyer, Elsa S. .
DIABETES CARE, 2016, 39 (05) :801-807
[8]   Distal Symmetric Polyneuropathy A Review [J].
Callaghan, Brian C. ;
Price, Raymond S. ;
Feldman, Eva L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (20) :2172-2181
[9]   Diabetic neuropathy: clinical manifestations and current treatments [J].
Callaghan, Brian C. ;
Cheng, Hsinlin T. ;
Stables, Catherine L. ;
Smith, Andrea L. ;
Feldman, Eva L. .
LANCET NEUROLOGY, 2012, 11 (06) :521-534
[10]   THE PREVALENCE BY STAGED SEVERITY OF VARIOUS TYPES OF DIABETIC NEUROPATHY, RETINOPATHY, AND NEPHROPATHY IN A POPULATION-BASED COHORT - THE ROCHESTER DIABETIC NEUROPATHY STUDY [J].
DYCK, PJ ;
KRATZ, KM ;
KARNES, JL ;
LITCHY, WJ ;
KLEIN, R ;
PACH, JM ;
WILSON, DM ;
OBRIEN, PC ;
MELTON, LJ .
NEUROLOGY, 1993, 43 (04) :817-824